ProPhase Labs, Inc. Forecast, price target & analysts
ProPhase Labs, Inc. Target price 2025 - Analyst rating & recommendation
ProPhase Labs, Inc. Classifications & Recommendation:
ProPhase Labs, Inc. Price Target
| Target Price | $16.32 |
| Price | $0.28 |
| Potential |
5,672.90%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target ProPhase Labs, Inc. 2026 .
The average ProPhase Labs, Inc. target price is $16.32.
This is
5,672.90%
register free of charge
$16.80
5,842.70%
register free of charge
$16.16
5,616.31%
register free of charge
|
|
| A rating was issued by 7 analysts: 6 Analysts recommend ProPhase Labs, Inc. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the ProPhase Labs, Inc. stock has an average upside potential 2026 of
5,672.90%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 6.77 | 21.79 |
| 80.65% | 221.82% | |
| EBITDA Margin | -479.17% | 88.72% |
| 1,004.91% | 118.52% | |
| Net Margin | -788.18% | -108.91% |
| 1,543.07% | 86.18% |
3 Analysts have issued a sales forecast ProPhase Labs, Inc. 2025 . The average ProPhase Labs, Inc. sales estimate is
This results in the following potential growth metrics:
Revenue Estimates
| 2024 | $6.8m | 80.65% |
|---|---|---|
| 2025 |
$21.8m
221.82%
Unlock
|
|
3 Analysts have issued an ProPhase Labs, Inc. EBITDA forecast 2025. The average ProPhase Labs, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2024 | $-32.4m | 113.84% |
|---|---|---|
| 2025 |
$19.3m
159.58%
Unlock
|
|
EBITDA Margin
| 2024 | -479.17% | 1,004.91% |
|---|---|---|
| 2025 |
88.72%
118.52%
Unlock
|
|
3 ProPhase Labs, Inc. Analysts have issued a net profit forecast 2025. The average ProPhase Labs, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2024 | $-53.4m | 218.00% |
|---|---|---|
| 2025 |
$-23.7m
55.53%
Unlock
|
|
Net Margin
| 2024 | -788.18% | 1,543.07% |
|---|---|---|
| 2025 |
-108.91%
86.18%
Unlock
|
|
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -2.60 | -0.57 |
| 168.04% | 78.08% | |
| P/E | negative | |
| EV/Sales | 0.89 |
3 Analysts have issued a ProPhase Labs, Inc. forecast for earnings per share. The average ProPhase Labs, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2024 | $-2.60 | 168.04% |
|---|---|---|
| 2025 |
$-0.57
78.08%
Unlock
|
|
P/E ratio
| Current | -1.66 | 12.67% |
|---|---|---|
| 2025 |
-0.49
70.53%
Unlock
|
|
Based on analysts' sales estimates for 2025, the ProPhase Labs, Inc. stock is valued at an EV/Sales of
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 3.32 | 23.68% |
|---|---|---|
| 2025 |
0.89
73.28%
Unlock
|
|
P/S ratio
| Current | 2.02 | 36.99% |
|---|---|---|
| 2025 |
0.54
73.29%
Unlock
|
|
ProPhase Labs, Inc....
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
